Hormonal contraceptives should be available without a prescription

CDC and HHS leadership, research integrity, bioethics, regulatory appointments, e-cigarette regulation, and global health funding.

Medicaid, Medicare, ACA, NHS, insurance coverage, prior authorization, healthcare workforce, and access disparities.

Medicare Part B/D, Medicare Advantage, IRA drug negotiations, 340B, most-favored-nation pricing, and federal drug pricing policy.

Medicaid cuts, funding freezes, state waivers, directed payments, CHIP, and state-level healthcare access policies.

Medical debt, out-of-pocket costs, voter concerns, racial disparities, rural access, and international healthcare access.

Nurse shortages, telehealth expansion, NHS workforce, hospital consolidation, and psychiatric care access.

ACA enrollment, premiums, marketplace cancellations, Essential Plan, uninsured rate, and insurance regulation.

Adherence to laws and safety standards.

IVF access, surrogacy regulation, contraception policy, maternal mortality disparities, and fertility preservation coverage.

FDA oversight of drug approvals, drug scheduling, pharmaceutical tariffs, medical device regulation, and drug safety enforcement.

Gaps in access to affordable birth control across the United States.